- Home
- DYAI vs WVVI Comparison
DYAI vs WVVI Comparison
Compare DYAI & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYAI
- WVVI
- Stock Information
- Founded
- DYAI 1979
- WVVI 1983
- Country
- DYAI United States
- WVVI United States
- Employees
- DYAI N/A
- WVVI N/A
- Industry
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- WVVI Beverages (Production/Distribution)
- Sector
- DYAI Health Care
- WVVI Consumer Staples
- Exchange
- DYAI Nasdaq
- WVVI Nasdaq
- Market Cap
- DYAI 28.3M
- WVVI 28.2M
- IPO Year
- DYAI 2004
- WVVI N/A
- Fundamental
- Price
- DYAI $0.98
- WVVI $5.24
- Analyst Decision
- DYAI Strong Buy
- WVVI
- Analyst Count
- DYAI 1
- WVVI 0
- Target Price
- DYAI $6.00
- WVVI N/A
- AVG Volume (30 Days)
- DYAI 63.9K
- WVVI 26.2K
- Earning Date
- DYAI 08-12-2025
- WVVI 08-12-2025
- Dividend Yield
- DYAI N/A
- WVVI N/A
- EPS Growth
- DYAI N/A
- WVVI N/A
- EPS
- DYAI N/A
- WVVI N/A
- Revenue
- DYAI $3,554,344.00
- WVVI $38,520,945.00
- Revenue This Year
- DYAI $22.56
- WVVI N/A
- Revenue Next Year
- DYAI $30.95
- WVVI N/A
- P/E Ratio
- DYAI N/A
- WVVI N/A
- Revenue Growth
- DYAI 57.59
- WVVI N/A
- 52 Week Low
- DYAI $0.91
- WVVI $3.17
- 52 Week High
- DYAI $2.20
- WVVI $7.18
- Technical
- Relative Strength Index (RSI)
- DYAI 53.08
- WVVI 39.81
- Support Level
- DYAI $0.91
- WVVI $5.21
- Resistance Level
- DYAI $0.99
- WVVI $5.75
- Average True Range (ATR)
- DYAI 0.06
- WVVI 0.37
- MACD
- DYAI 0.01
- WVVI -0.00
- Stochastic Oscillator
- DYAI 59.93
- WVVI 47.74
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.